focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Share News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Jefferies And Shore Say Hold AstraZeneca

Wed, 11th May 2016 08:37

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
Shore Capital Initiates AstraZeneca At Hold
----------
JEFFERIES CUTS ASTRAZENECA PRICE TARGET TO 3900 (4200) PENCE - 'HOLD'
----------
JEFFERIES CUTS GLAXOSMITHKLINE PRICE TARGET TO 1500 (1550) PENCE - 'HOLD'
----------
UBS RAISES UNILEVER PRICE TARGET TO 3080 (2800) PENCE - 'NEUTRAL'
----------
UBS CUTS EASYJET PRICE TARGET TO 1585 (1635) PENCE - 'NEUTRAL'
----------
UBS RAISES INTERTEK PRICE TARGET TO 3650 (3200) PENCE - 'BUY'
----------
JPMORGAN CUTS BURBERRY GROUP PRICE TARGET TO 1330 (1360) PENCE - 'NEUTRAL'
----------
Societe Generale Ups 3i Group Target To 440p From 435p, Keeps Buy
----------
SOCGEN RAISES BT GROUP PRICE TARGET TO 545 (535) PENCE - 'BUY'
----------
GOLDMAN CUTS BABCOCK INTERNATIONAL PRICE TARGET TO 1284 (1302) PENCE - 'BUY'
----------
JPMORGAN RAISES PEARSON PRICE TARGET TO 805 (760) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES INFORMA PRICE TARGET TO 765 (710) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS RBS PRICE TARGET TO 240 (260) PENCE - 'HOLD'
----------
FTSE 250
----------
Investec Upgrades Dairy Crest Group To Buy From Hold Cuts Price Target To 625p From 636p
----------
Berenberg Ups Spire Healthcare Group Target To 395p From 390p, Keeps Buy
----------
RBC CAPITAL CUTS BERENDSEN TO 'SECTOR PERFORM' (OUTPERFORM) - TARGET 1200 PENCE
----------
JPMORGAN RAISES CRODA INTERNATIONAL PRICE TARGET TO 3314 (3200) PENCE - 'OW'
----------
MAIN MARKET AND AIM
----------
Numis Upgrades Volution Group To Add From Hold, Target At 184p
----------
Numis Upgrades TT Electronics To Buy From Add, Target At 170p
----------
Numis Upgrades Recommendation On Cape To Buy From Add
----------
PANMURE CUTS CLUFF NATURAL RESOURCES PRICE TARGET TO 2 (8) PENCE - 'BUY'
----------
PANMURE RESUMES EKF DIAGNOSTICS WITH 'BUY' - TARGET 14 PENCE
----------
N+1 Cuts Horizon Discovery Group To Hold From Buy, Target To 194p From 196p
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
26 Apr 2016 10:28

Horizon Discovery Loss Widens As Investments Offset Revenue Growth

Read more
19 Apr 2016 15:05

Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
2 Mar 2016 08:47

Horizon Discovery Forms Joint Venture With Centauri Therapeutics

Read more
18 Jan 2016 07:44

Horizon Discovery Expecting 2015 Results To Beat Market Consensus

Read more
17 Dec 2015 10:34

DIRECTOR DEALINGS: Horizon Discovery Non-Executive Buys Shares

Read more
25 Nov 2015 09:04

Horizon Discovery Group Inks Development Deals Worth USD3.3 Million

Read more
13 Nov 2015 09:47

DIRECTOR DEALINGS: Seven Horizon Discovery Directors Buy Shares

Read more
12 Nov 2015 13:50

Horizon Discovery Chief Business Officer David Smoller Steps Down

Read more
28 Oct 2015 09:25

Horizon Discovery Launches E-Commerce Platform Expands UK Base

Read more
7 Oct 2015 15:13

Horizon Discovery Issues Deferred Consideration Shares For Sage Labs (ALLISS)

Read more
7 Oct 2015 07:41

Horizon Discovery Signs In-Licensing Deal With France's Servier

Read more
22 Sep 2015 09:47

Horizon Discovery Confident As First Half Loss Widens On Investments

Read more
16 Sep 2015 15:59

Horizon Discovery signs Chinese hamster ovary cell deal with LakePharma

(ShareCast News) - Horizon Discovery Group's bioproduction business has signed a license agreement with LakePharma over the commercial use of a genetically-engineered Chinese Hamster Ovary (CHO) cell line. Horizon's Chief Executive Dr Darrin Disley said the agreement serves as recognition and valida

Read more
16 Sep 2015 07:01

Horizon Discovery Inks Chinese Hamster Ovary Deal With LakePharma

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.